AGF Investments Inc’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-662,866
| Closed | -$5.31M | – | 686 |
|
|
2021
Q4 | $5.31M | Sell |
662,866
-157,791
| -19% | -$1.42M | 0.04% | 242 |
|
|
2021
Q3 | $7.99M | Sell |
820,657
-83,710
| -9% | -$784K | 0.06% | 197 |
|
|
2021
Q2 | $8.95M | Sell |
904,367
-121,228
| -12% | -$1.28M | 0.07% | 195 |
|
|
2021
Q1 | $11.8M | Sell |
1,025,595
-93,488
| -8% | -$1.07M | 0.09% | 186 |
|
|
2020
Q4 | $10.8M | Sell |
1,119,083
-223,588
| -17% | -$2.14M | 0.09% | 179 |
|
|
2020
Q3 | $12.1M | Sell |
1,342,671
-14,180
| -1% | -$150K | 0.12% | 167 |
|
|
2020
Q2 | $16.7M | Sell |
1,356,851
-66,964
| -5% | -$757K | 0.18% | 148 |
|
|
2020
Q1 | $12.8M | Buy |
1,423,815
+39,614
| +3% | +$406K | 0.15% | 144 |
|
|
2019
Q4 | $13.6M | Sell |
1,384,201
-55,020
| -4% | -$491K | 0.16% | 139 |
|
|
2019
Q3 | $9.9M | Sell |
1,439,221
-113,773
| -7% | -$872K | 0.12% | 150 |
|
|
2019
Q2 | $14.3M | Sell |
1,552,994
-502,048
| -24% | -$6.05M | 0.17% | 134 |
|
|
2019
Q1 | $32.2M | Buy |
2,055,042
+527,680
| +35% | +$9.31M | 0.36% | 89 |
|
|
2018
Q4 | $23.6M | Buy |
1,527,362
+108,367
| +8% | +$2.22M | 0.28% | 113 |
|
|
2018
Q3 | $30.6M | Buy |
1,418,995
+449,936
| +46% | +$10.4M | 0.31% | 102 |
|
|
2018
Q2 | $23.6M | Sell |
969,059
-49,670
| -5% | -$1.01M | 0.24% | 118 |
|
|
2018
Q1 | $17.4M | Buy |
1,018,729
+17,065
| +2% | +$333K | 0.19% | 140 |
|
|
2017
Q4 | $19M | Sell |
1,001,664
-72,891
| -7% | -$1.1M | 0.18% | 144 |
|
|
2017
Q3 | $18.9M | Sell |
1,074,555
-809,811
| -43% | -$18.2M | 0.21% | 132 |
|
|
2017
Q2 | $62.6M | Buy |
1,884,366
+335,122
| +22% | +$10.4M | 0.72% | 47 |
|
|
2017
Q1 | $49.7M | Buy |
1,549,244
+84,133
| +6% | +$2.87M | 0.54% | 64 |
|
|
2016
Q4 | $53.1M | Buy |
1,465,111
+231,490
| +19% | +$9.24M | 0.61% | 59 |
|
|
2016
Q3 | $56.7M | Sell |
1,233,621
-19,087
| -2% | -$996K | 0.64% | 59 |
|
|
2016
Q2 | $62.9M | Buy |
1,252,708
+300,224
| +32% | +$16M | 0.7% | 48 |
|
|
2016
Q1 | $50.9M | Buy |
952,484
+51,305
| +6% | +$3.01M | 0.61% | 59 |
|
|
2015
Q4 | $59.2M | Buy |
901,179
+259,158
| +40% | +$16M | 0.73% | 45 |
|
|
2015
Q3 | $36.4M | Buy |
642,021
+36,180
| +6% | +$2.35M | 0.46% | 78 |
|
|
2015
Q2 | $35.8M | Sell |
605,841
-22,198
| -4% | -$1.37M | 0.39% | 86 |
|
|
2015
Q1 | $39.1M | Sell |
628,039
-74,271
| -11% | -$4.32M | 0.43% | 84 |
|
|
2014
Q4 | $40.4M | Sell |
702,310
-34,873
| -5% | -$1.94M | 0.43% | 89 |
|
|
2014
Q3 | $39.7M | Sell |
737,183
-7,517
| -1% | -$398K | 0.41% | 95 |
|
|
2014
Q2 | $39M | Buy |
744,700
+8,155
| +1% | +$417K | 0.38% | 95 |
|
|
2014
Q1 | $38.9M | Sell |
736,545
-681,406
| -48% | -$31.5M | 0.4% | 91 |
|
|
2013
Q4 | $56.9M | Sell |
1,417,951
-246,396
| -15% | -$9.7M | 0.58% | 54 |
|
|
2013
Q3 | $62.8M | Sell |
1,664,347
-271,180
| -14% | -$10.6M | 0.71% | 35 |
|
|
2013
Q2 | $75.9M | Buy |
+1,935,527
| New | +$75.4M | 0.88% | 30 |
|
Other funds holding TEVA
ACM
MMH
MIFH
CI
PF
HIIFS
AGF Investments Inc's TEVA Position: Q1 2022 in Review
AGF Investments Inc sold out of Teva Pharmaceuticals (TEVA) in Q1 2022, closing a stake of 662,866 shares — an estimated $5.31M sold.
AGF Investments Inc first reported a position in TEVA in Q2 2013 and held it in 35 quarters. The position peaked at $75.9M in Q2 2013. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2022.
- AGF Investments Inc reported no remaining Teva Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
- AGF Investments Inc sold 662,866 Teva Pharmaceuticals shares in Q1 2022, an estimated $5.31M.
- AGF Investments Inc first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 35 quarters.
- AGF Investments Inc's Teva Pharmaceuticals position peaked at $75.9M in Q2 2013.
- 438 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2022.
Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.